Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OLODATEROL\TIOTROPIUM for Lung neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where OLODATEROL\TIOTROPIUM was used for Lung neoplasm malignant.

Most Reported Side Effects for OLODATEROL\TIOTROPIUM

Side Effect Reports % Deaths Hosp.
Dyspnoea 1,149 25.9% 28 489
Wheezing 575 13.0% 6 408
Asthma 526 11.9% 7 402
Cough 485 11.0% 4 217
Drug ineffective 403 9.1% 7 172
Chronic obstructive pulmonary disease 373 8.4% 32 245
Therapeutic product effect incomplete 319 7.2% 0 238
Loss of personal independence in daily activities 307 6.9% 6 225
Pneumonia 280 6.3% 24 245
Off label use 265 6.0% 15 91
Sleep disorder due to a general medical condition 259 5.9% 6 197
Bronchiectasis 199 4.5% 0 155
Death 186 4.2% 186 18
Chest discomfort 175 4.0% 0 117
Asthma-chronic obstructive pulmonary disease overlap syndrome 171 3.9% 0 129

Other Indications for OLODATEROL\TIOTROPIUM

Product used for unknown indication (2,048) Chronic obstructive pulmonary disease (1,881) Asthma (165) Emphysema (141) Dyspnoea (52) Bronchitis chronic (19) Lung disorder (19) Bronchiectasis (18) Bronchitis (10) Cough (8)

Other Drugs Used for Lung neoplasm malignant

ERLOTINIB (9,207) OSIMERTINIB (4,754) NIVOLUMAB (4,197) PEMBROLIZUMAB (3,575) CARBOPLATIN (3,487) ALECTINIB (2,932) PEMETREXED (2,422) CRIZOTINIB (1,949) BEVACIZUMAB (1,810) PACLITAXEL (1,747)

Related Pages

OLODATEROL\TIOTROPIUM Full Profile All Lung neoplasm malignant Drugs OLODATEROL\TIOTROPIUM Demographics OLODATEROL\TIOTROPIUM Timeline